Rankings
▼
Calendar
SNDX FY 2021 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$140M
+9109.6% YoY
Gross Profit
$140M
100.0% margin
Operating Income
$26M
18.8% margin
Net Income
$25M
17.8% margin
EPS (Diluted)
$0.48
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$29M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$450M
Total Liabilities
$41M
Stockholders' Equity
$408M
Cash & Equivalents
$222M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$140M
$2M
+9109.6%
Gross Profit
$140M
$2M
+9109.6%
Operating Income
$26M
-$71M
+136.7%
Net Income
$25M
-$73M
+134.1%
← Q4 2020
All Quarters
Q1 2021 →